Skip to main content
. 2022 Oct 3;12:1024600. doi: 10.3389/fonc.2022.1024600

Table 2.

Summary of molecules for targeting phase-separation for treating treatment-resistant malignancy.

Protein complex Molecules/Screning Molecular function Tumor model Ref
HOXB8/FOSL1 GSK-J4
Screening by 303 chemicals
H3K27 demethylase inhibitor Osteosarcoma 118
SRC3/NSD2 SI-2
High throughput cell-based
luciferase assay screening
small molecules
interacting with SRC-3
Multiple myeloma 119, 120
OCT4/AR/FOXA1
OCT4/NRF1
Ribavirin
In silico screening by using Connectivity Map
nuclear analogue Prostate cancer 81, 113
YAP/TAZ/SRC1 Elvitegravir
YAP reporter cell-based screening
integrase inhibitor Lung cancer 121